Assignee profile:

Bind Therapeutics, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

36

Last publication date:

2017-03-30

Patent Grants:

30

Last grant date:

2018-07-17

Top Inventors for applications by Bind Therapeutics, Inc.

These are the the leading inventors for applications assigned to Bind Therapeutics, Inc.:

Recent patent applications by Bind Therapeutics, Inc.

Bind Therapeutics, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-03-30 ✅ Patent 10,022,360 granted on 2018-07-17
US20170087135A1
Human necessities

Polymeric nanoparticles and methods of making and using same

#2 | 2015-04-23
US20150110837A9
Human necessities

Therapeutic Polymeric Nanoparticles Comprising Epothilone and Methods of Making and Using Same

#3 | 2015-02-26
US20150056300A1
Human necessities

THERAPEUTIC NANOPARTICLES WITH HIGH MOLECULAR WEIGHT COPOLYMERS

#4 | 2015-01-15 ✅ Patent 9,358,215 granted on 2016-06-07
US20150018412A1
Human necessities

High throughput fabrication of nanoparticles

#5 | 2014-12-04 ✅ Patent 9,375,481 granted on 2016-06-28
US20140356444A1
Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#6 | 2014-10-16
US20140308363A1
Human necessities

DRUG LOADED POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME

#7 | 2014-09-04
US20140249158A1
Human necessities

Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same

#8 | 2014-09-04
US20140248358A1
Human necessities

Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same

#9 | 2014-08-21 ✅ Patent 9,295,727 granted on 2016-03-29
US20140235706A1
Human necessities

Cancer cell targeting using nanoparticles

#10 | 2014-07-03 ✅ Patent 9,579,284 granted on 2017-02-28
US20140186453A1
Human necessities

Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same

#11 | 2014-07-03 ✅ Patent 9,877,923 granted on 2018-01-30
US20140186452A1
Human necessities

Process for preparing therapeutic nanoparticles

#12 | 2014-06-26
US20140178475A1
Human necessities

Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same

#13 | 2014-05-22 ✅ Patent 8,905,997 granted on 2014-12-09
US20140142165A1
Human necessities

Therapeutic particles suitable for parenteral administration and methods of making and using same

#14 | 2014-04-03 ✅ Patent 9,198,874 granted on 2015-12-01
US20140093579A1
Human necessities

Long circulating nanoparticles for sustained release of therapeutic agents

#15 | 2014-01-30 ✅ Patent 8,912,212 granted on 2014-12-16
US20140030351A1
Human necessities

Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers

#16 | 2013-12-26 ✅ Patent 8,623,417 granted on 2014-01-07
US20130344158A1
Human necessities

Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same

#17 | 2013-11-14 ✅ Patent 8,663,700 granted on 2014-03-04
US20130302433A1
Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#18 | 2013-11-14 ✅ Patent 8,617,608 granted on 2013-12-31
US20130302432A1
Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#19 | 2013-11-07 ✅ Patent 8,603,535 granted on 2013-12-10
US20130295191A1
Human necessities

Stable formulations for lyophilizing therapeutic particles

#20 | 2013-11-07 ✅ Patent 8,637,083 granted on 2014-01-28
US20130295183A1
Human necessities

Stable formulations for lyophilizing therapeutic particles

#21 | 2013-10-24 ✅ Patent 8,603,534 granted on 2013-12-10
US20130280339A1
Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#22 | 2013-09-26 ✅ Patent 8,603,500 granted on 2013-12-10
US20130251817A1
Human necessities

Cancer cell targeting using nanoparticles

#23 | 2013-09-26 ✅ Patent 8,603,499 granted on 2013-12-10
US20130251816A1
Human necessities

Cancer cell targeting using nanoparticles

#24 | 2013-09-26 ✅ Patent 8,603,501 granted on 2013-12-10
US20130251766A1
Human necessities

Cancer cell targeting using nanoparticles

#25 | 2013-09-26 ✅ Patent 8,609,142 granted on 2013-12-17
US20130251757A1
Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#26 | 2013-09-19 ✅ Patent 8,916,203 granted on 2014-12-23
US20130243863A1
Human necessities

Stable formulations for lyophilizing therapeutic particles

#27 | 2013-09-19 ✅ Patent 8,652,528 granted on 2014-02-18
US20130243827A1
Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#28 | 2013-09-05 ✅ Patent 8,956,657 granted on 2015-02-17
US20130230568A1
Human necessities

Stable formulations for lyophilizing therapeutic particles

#29 | 2013-09-05 ✅ Patent 8,613,954 granted on 2013-12-24
US20130230567A1
Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#30 | 2013-07-25 ✅ Patent 9,351,933 granted on 2016-05-31
US20130189315A1
Human necessities

Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same

#31 | 2013-02-07 ✅ Patent 9,308,179 granted on 2016-04-12
US20130034608A1
Human necessities

Long circulating nanoparticles for sustained release of therapeutic agents

#32 | 2012-11-01 ✅ Patent 9,393,310 granted on 2016-07-19
US20120276162A1
Human necessities

Drug loaded polymeric nanoparticles and methods of making and using same

#33 | 2012-06-07 ✅ Patent 8,518,963 granted on 2013-08-27
US20120140790A1
Physics

Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers

#34 | 2011-12-01 ✅ Patent 9,295,649 granted on 2016-03-29
US20110294717A1
Physics

Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers

#35 | 2010-09-09 ✅ Patent 8,563,041 granted on 2013-10-22
US20100226986A1
Human necessities

Therapeutic particles suitable for parenteral administration and methods of making and using same

#36 | 2010-03-18 ✅ Patent 8,613,951 granted on 2013-12-24
US20100069426A1
Human necessities

Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same

Also check out Bind Therapeutics, Inc.'s (Cambridge, United States) applicant profile with 20 patent applications submitted.

AssigneeID:

37717 ⎘